OXIS INTL INC (OXIS)

OXIS develops, commercializes, and addresses existing clinical shortcomings of related products with innovative drugs containing therapeutic molecules such as CANNABINOIDS, which are focused on several cancer indicators. Utilizing the powerful compounds found in cannabinoid-producing plants, OXIS will produce a platform of synthesized cannabinoid agents that target the treatment of cancer cells in multiple areas.

OWC Pharmaceutical Research Corp (OWCP) PEAK PHARMACEUTICLS (PMCB)

Stammdaten
WKN: 860181 ISIN: US6918294025 Kürzel: OXIS
Börsenplätze Realtimekurs Vorbörsliche Indikation Nachbörsliche Indikation Times & Sales
Weitere Infos
Unternehmen / Vorstand Shortpositionen Insidergeschäfte Bekanntgaben & Bilanzen Finanzen Homepage Börsenwert
Gründungsjahr
k.A.
Haupthandelsplatz
Vollzogene Namenswechsel
- DDI Pharmaceuticals, Inc. until 9-94
Land
in  handelbar: JA
Angestellte: 2

Stand 20.06.2015